What is the intrinsic value of NXG.V?

As of 2025-05-21, the Intrinsic Value of NexgenRx Inc (NXG.V) is 0.21 CAD. This NXG.V valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.30 CAD, the upside of NexgenRx Inc is -28.50%.

The range of the Intrinsic Value is 0.18 - 0.27 CAD

Is NXG.V undervalued or overvalued?

Based on its market price of 0.30 CAD and our intrinsic valuation, NexgenRx Inc (NXG.V) is overvalued by 28.50%.

	Range	Selected	Upside
a
DCF (Growth 5y)	0.18 - 0.27	0.21	-28.5%
DCF (Growth 10y)	0.22 - 0.33	0.26	-13.6%
DCF (EBITDA 5y)	0.15 - 0.32	0.16	-45.1%
DCF (EBITDA 10y)	0.19 - 0.38	0.21	-29.1%
Fair Value	0.04 - 0.04	0.04	-85.60%
P/E	0.07 - 0.28	0.22	-26.8%
EV/EBITDA	0.18 - 0.71	0.30	-0.1%
EPV	0.44 - 0.59	0.52	72.0%
DDM - Stable	0.08 - 0.16	0.12	-59.9%
DDM - Multi	0.17 - 0.26	0.20	-32.2%